116 related articles for article (PubMed ID: 10368252)
1. The expression of PAX5 in human transitional cell carcinoma of the bladder: relationship with de-differentiation.
Adshead JM; Ogden CW; Penny MA; Stuart ET; Kessling AM
BJU Int; 1999 Jun; 83(9):1039-44. PubMed ID: 10368252
[TBL] [Abstract][Full Text] [Related]
2. The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome.
Babjuk M; Soukup V; Mares J; Dusková J; Sedlácek Z; Trková M; Pecen L; Dvorácek J; Hanus T; Kocvara R; Novák J; Povýsil C
Int Urol Nephrol; 2002; 34(4):495-501. PubMed ID: 14577491
[TBL] [Abstract][Full Text] [Related]
3. EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder.
Hinz S; Kempkensteffen C; Weikert S; Schostak M; Schrader M; Miller K; Christoph F
Tumour Biol; 2007; 28(3):151-7. PubMed ID: 17541304
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
5. Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder.
Babjuk M; Soukup V; Mares J; Dusková J; Pecen L; Pesl M; Pavlík I; DvorRcek J
Urology; 2006 Apr; 67(4):756-61. PubMed ID: 16566978
[TBL] [Abstract][Full Text] [Related]
6. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Rath SK; Dalela D; Goel MM; Bhatt ML
Immunobiology; 2015 Jan; 220(1):103-8. PubMed ID: 25178936
[TBL] [Abstract][Full Text] [Related]
8. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
Immunobiology; 2015 Jan; 220(1):68-73. PubMed ID: 25214475
[TBL] [Abstract][Full Text] [Related]
9. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.
Aaltonen V; Boström PJ; Söderström KO; Hirvonen O; Tuukkanen J; Nurmi M; Laato M; Peltonen J
Am J Pathol; 1999 Mar; 154(3):755-65. PubMed ID: 10079253
[TBL] [Abstract][Full Text] [Related]
10. Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis.
Schlott T; Quentin T; Korabiowska M; Budd B; Kunze E
Int J Mol Med; 2004 Nov; 14(5):825-36. PubMed ID: 15492852
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of vascular endothelial growth factor a dynamic expression in transitional cell carcinoma.
Ping SY; Shen KH; Yu DS
Mol Carcinog; 2013 Jul; 52(7):568-79. PubMed ID: 22392726
[TBL] [Abstract][Full Text] [Related]
12. PTCH gene mutations in invasive transitional cell carcinoma of the bladder.
McGarvey TW; Maruta Y; Tomaszewski JE; Linnenbach AJ; Malkowicz SB
Oncogene; 1998 Sep; 17(9):1167-72. PubMed ID: 9764827
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
14. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Ku 70 and Ku 80 mRNA expression in transitional cell carcinomas of the urinary bladder related to tumor progression.
Korabiowska M; Quentin T; Schlott T; Bauer H; Kunze E
World J Urol; 2004 Dec; 22(6):431-40. PubMed ID: 15551138
[TBL] [Abstract][Full Text] [Related]
17. Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
Baffa R; Gomella LG; Vecchione A; Bassi P; Mimori K; Sedor J; Calviello CM; Gardiman M; Minimo C; Strup SE; McCue PA; Kovatich AJ; Pagano F; Huebner K; Croce CM
Am J Pathol; 2000 Feb; 156(2):419-24. PubMed ID: 10666370
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.
Raman JD; Mongan NP; Tickoo SK; Boorjian SA; Scherr DS; Gudas LJ
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8570-6. PubMed ID: 16361539
[TBL] [Abstract][Full Text] [Related]
19. The expression of urokinase-related genes in superficial and invasive transitional cell carcinoma.
McGarvey TW; Kariko K; Barnathan ES; Thomas J; Malkowicz SB
Int J Oncol; 1998 Jan; 12(1):175-80. PubMed ID: 9454902
[TBL] [Abstract][Full Text] [Related]
20. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]